Skip to main content
. 2023 Feb 13;15(2):621. doi: 10.3390/pharmaceutics15020621

Figure 1.

Figure 1

The preparation and characterization of red-cell-membrane-coated nanoparticles for ND drug delivery. (A) The preparation and characterization of SHp-RBC-NP/NR2B9C for ischemic stroke drug delivery; (B) the preparation and characterization of RGD-RBC-NC(DTX) for glioma drug delivery; (C) the preparation and characterization of DWSW/NGR-RBCNPs for glioma drug delivery; (D) the preparation and characterization of DCDX-RBCNP for glioma drug delivery; and (E) the preparation and characterization of Vir-Gel for glioblastoma drug delivery.